Stockholders' Equity (Details) - USD ($)				3 Months Ended	6 Months Ended	12 Months Ended
	May 04, 2023	Jan. 11, 2023	Oct. 03, 2022	Jun. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	May 31, 2023	Jun. 24, 2022
Stockholders' Equity (Details) [Line Items]
Common stock share authorized				100,000,000	100,000,000	100,000,000
Common stock issued	605,000		268,000	6,967,699	6,967,699	2,899,911
Common stock outstanding				6,967,699	6,967,699	2,899,911
Preferred shares authorized				10,000,000	10,000,000	10,000,000
Sale of shares						85,732
Gross proceeds (in Dollars)	$ 3,500,000					$ 1,030,000.00
Net proceeds (in Dollars)	$ 3,000,000		$ 3,040,000.00			$ 990,000
Common stock, par value (in Dollars per share)	$ 0.01		$ 0.01	$ 0.01	$ 0.01	$ 0.01
Stated value per share (in Dollars per share)				$ 0.01	$ 0.01	0.01
Pre-funded warrants	3,890,825		215,000
Number of repriced warrants to purchase shares	6,396,903
Exercise price of common warrants (in Dollars per share)	$ 0.7785	$ 2.65
Existing warrants description			provide that the existing warrants, as amended, will not be exercisable until six months following the closing date of the offering
Common warrant expiration date			expiration date of the existing warrants by five and one-half years
Increase in fair value from warrant modification (in Dollars)	$ 300,000		$ 1,800,000
Common warrants issued	4,495,825
Price per share of common stock and accompanying common warrant (in Dollars per share)	$ 0.7785
Price per share of pre-funded warrant and common warrants (in Dollars per share)	0.7685
Pre-funded warrant has an exercise price (in Dollars per share)	$ 0.01
Warrant exercise price	0.7785
2015 Plan [Member]
Stockholders' Equity (Details) [Line Items]
Authorized issuance share				2,710	2,710
Stock option, description					In addition, the number of shares that have been authorized for issuance under the 2015 Plan will be automatically increased on the first day of each fiscal year beginning on January 1, 2016 and ending on (and including) January 1, 2025, in an amount equal to the lesser of (1) 4% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, or (2) another lesser amount determined by the Company’s Board of Directors.
Shares added				115,996	115,996
Remaining shares				81,646	81,646
Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, par value (in Dollars per share)	$ 0.01		$ 0.01
Number of repriced warrants to purchase shares			741,489
Minimum [Member]
Stockholders' Equity (Details) [Line Items]
Minimum warrant exercise price from prior offerings (in Dollars per share)	2.65		$ 41
Maximum [Member]
Stockholders' Equity (Details) [Line Items]
Maximum warrant exercise price from prior offerings (in Dollars per share)	$ 7.54		$ 1,300
First Annual Anniversary [Member]
Stockholders' Equity (Details) [Line Items]
Vesting award, percentage					6.25%
Series C Mirroring Preferred Stock [Member]
Stockholders' Equity (Details) [Line Items]
Shares			33,810
Par value per share (in Dollars per share)			$ 0.01
Stated value per share (in Dollars per share)			$ 0.01
Warrant [Member]
Stockholders' Equity (Details) [Line Items]
Gross proceeds (in Dollars)			$ 3,340,000
Offering price per share of pre-funded warrant (in Dollars per share)			$ 6.8
Exercise price of common warrants (in Dollars per share)						$ 215,000
Exercise price of common warrants (in Dollars per share)							$ 0.7785
Pre-funded warrant has an exercise price (in Dollars per share)			$ 6.8
Private Placement [Member]
Stockholders' Equity (Details) [Line Items]
Warrants issued to purchase common stock			483,000
Stock options [Member]
Stockholders' Equity (Details) [Line Items]
Stock options to acquire shares of common stock					107,597
Common Stock [Member] | Minimum [Member] | H.C. Wainwright & Co., LLC [Member] | 2020 ATM Offering [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate share (in Dollars)								$ 10,650,000
Exercise Agreement [Member] | PIPE Financing [Member]
Stockholders' Equity (Details) [Line Items]
price per share of prefunded warrants and common warrants (in Dollars per share)			$ 7
Price per share of preferred stock (in Dollars per share)			0.01
Securities Purchase Agreement [Member]
Stockholders' Equity (Details) [Line Items]
Common stock issued		321,207
Prefunded warrants		2,265,000
Prefunded Warrants Offering Price Per Share (in Dollars per share)		$ 2.89
Securities Purchase Agreement [Member] | Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Shares of common stock		321,207
Par value of common stock (in Dollars)		$ 0.01
price per share of PRE-FUNDED warrant and common warrants (in Dollars per share)		$ 2.9
Securities Purchase Agreement [Member] | Pre-funded Warrant [Member]
Stockholders' Equity (Details) [Line Items]
Prefunded Warrants Offering Price Per Share (in Dollars per share)		$ 2.89
Gross proceeds (in Dollars)		$ 7,500,000
Net proceeds (in Dollars)		$ 6,900,000
Series A-1 Common Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate warrants		2,586,207
Series A-2 Common Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Exercise price of common warrants (in Dollars per share)		$ 0.01
Aggregate warrants		2,586,207
Chief Financial Officer [Member]
Stockholders' Equity (Details) [Line Items]
Stock options granted					10,500
Exercise price of stock options (in Dollars per share)				$ 21.6	$ 21.6
Chief Financial Officer [Member] | First Annual Anniversary [Member]
Stockholders' Equity (Details) [Line Items]
Vesting award, percentage					25.00%
Restricted Stock Units (RSUs) [Member]
Stockholders' Equity (Details) [Line Items]
Stock units granted				7,500	100,500
Stock units vested				22,153	33,780
Stock units forfeited
Stock units outstanding					109,627
Investor [Member]
Stockholders' Equity (Details) [Line Items]
Exercise price of common warrants (in Dollars per share)			$ 7.54